Clinical and metabolic aspects of urinary stone disease in Leeds.
In summary, the persistent passage of urine excessively supersaturated with calcium oxalate and/or calcium phosphate in conjunction with a low level of inhibitory activity increases the risk of abnormal crystalluria and stones in a given individual. Treatment of the disorder must be aimed at correcting the abnormal risk factor(s) in that individual.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000150:complications; D002118:Calcium / Q000378:metabolism; D002129:Calcium Oxalate / Q000652:urine; D002648:Child; D003460:Crystallization; D003553:Cystine / Q000378:metabolism; D004739:England; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000378:metabolism; D014545:Urinary Calculi / Q000150:complications / Q000378:metabolism* / Q000652:urine
D002129:Calcium Oxalate; D014527:Uric Acid; D003553:Cystine; D002118:Calcium